Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche pulls EU application for Tecentriq in kidney cancer

biopharmadiveNovember 22, 2018

Tag: EU , Roche , Kidney Cancer , Tecentriq

PharmaSources Customer Service